Form 8-K - Current report:
SEC Accession No. 0001558370-25-009214
Filing Date
2025-07-14
Accepted
2025-07-14 07:15:41
Documents
14
Period of Report
2025-07-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nxtc-20250714x8k.htm   iXBRL 8-K 52881
2 EX-3.1 nxtc-20250714xex3d1.htm EX-3.1 10367
  Complete submission text file 0001558370-25-009214.txt   191716

Data Files

Seq Description Document Type Size
3 EX-101.SCH nxtc-20250714.xsd EX-101.SCH 4117
4 EX-101.DEF nxtc-20250714_def.xml EX-101.DEF 2852
5 EX-101.LAB nxtc-20250714_lab.xml EX-101.LAB 17909
6 EX-101.PRE nxtc-20250714_pre.xml EX-101.PRE 11818
16 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20250714x8k_htm.xml XML 5037
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 251120131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)